The Global Market for Botanical and Plant-Derived Drugs will Grow from $29.4 Billion in 2017 to around $39.6 Billion by 2022 with a CAGR of 6.1%
An overview of the botanical drug industry, with the overall plant-derived drug industry as a backdrop and the global market for these drugs going forward
Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
A focus on legal, prescription-required therapeutic medicines sold in the open market; the study does not specifically cover herbals generally sold as dietary supplements (i.e., to promote overall wellness rather than to address specific medical conditions or symptoms)
Examination of the industry structure, competition, and market drivers
Discussion of market size and segmentation, including breakdowns of sales by therapeutic area and geographic area
Observations and conclusions regarding the future of the botanical and plant-derived drug industry
This report is an analytical business tool whose primary purpose is to describe the botanical drug industry with the overall plant-derived drug industry as a backdrop and the global market for these drugs going forward.
For the purposes of this report, botanicals are those drugs that are FDA-approved under the botanical drug pathway, while plant-derived drugs are both botanicals as well as other approved drugs that contain a mixture of natural plant-derived and synthetic or semisynthetic substances.
The study's main focus is on legal, prescription-required therapeutic medicines sold in the open market. The study does not specifically cover herbals generally sold as dietary supplements (i.e., to promote overall wellness rather than to address a specific medical condition or symptoms). While there is a substantial market for these products, the medical value of many of these substances has not been demonstrated conclusively.
The Format Of The Study Is Organized Around The Following Topics:
Major types and applications of botanical drugs with plant-derived drugs as their backdrop.
Market size and segmentation, including the breakdown of sales by therapeutic area and geographic area.
Market projections through 2022.
Observations and conclusions regarding the future of the botanical and plant-derived drug industry.
Key Topics Covered:
2: Summary and Highlights
Trends and Drivers for Botanical Drug Development
3: Market and Technology Background
Brief History of Plant-Derived Medicines
Opportunity Lies Beyond What Is Known
U.S. Government Investment
Nutrition Science Partners Ltd. (Nestle Health): A Case Study
Botanical Drugs Defined
Understanding the Regulatory Process
Investigational New Drug Applications
The First and Second U.S. Approved Botanical Drug
Botanical Candidates in the Pipeline
A Growing Pipeline
Overall Pharma Landscape
Major Classes of Plant Drugs
A New Type of Production: Plant-Made Drugs
Drug Development and Manufacture
4: Market Breakdown by Technology Type
Sales of Plant-derived Drugs by Region
Plant-derived Drugs by Therapeutic Area
Value of Plant-derived Drugs by Therapeutic Area
A Pipeline Perspective: Composition of Botanical Drugs in Clinical Development
5: New Developments and Market Opportunities
Hormone Therapy and Metabolism Applications
Infectious Disease Applications
Pain and Central Nervous System Disease Applications
Cardiovascular and Metabolic Applications
Respiratory, Inflammation (Both Nonrelated and Related to Orthopedic) and Autoimmune Applications